220 related articles for article (PubMed ID: 35076853)
21. Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness.
De P; Sun Y; Carlson JH; Friedman LS; Leyland-Jones BR; Dey N
Neoplasia; 2014 Jan; 16(1):43-72. PubMed ID: 24563619
[TBL] [Abstract][Full Text] [Related]
22. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
Hong Y; Fan D
Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
[TBL] [Abstract][Full Text] [Related]
23. Activation of autophagy promotes the inhibitory effect of curcumin analog EF-24 against MDA-MB-231 cancer cells.
Zhao YY; Li J; Wang HQ; Zheng HB; Ma SW; Zhou GZ
J Biochem Mol Toxicol; 2024 Feb; 38(2):e23642. PubMed ID: 38348710
[TBL] [Abstract][Full Text] [Related]
24. ent-Kaurane-Type Diterpenes Induce ROS-Mediated Mitochondrial Dysfunction and Apoptosis by Suppress the Homologous Recombination DNA Repair in Triple-Negative Breast Cancer Cells.
Xie Y; Su Y; Liao Z; Liang X; Hua J; Zhang D; Hu D; Yu Q
Chem Biodivers; 2023 Aug; 20(8):e202300670. PubMed ID: 37448115
[TBL] [Abstract][Full Text] [Related]
25. 1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel.
Modi K; Lawson S; Chen G; Tumuluri D; Rekhtman I; Kurtz M; Brailoiu GC; Chen QH; Lakshmikuttyamma A
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806551
[TBL] [Abstract][Full Text] [Related]
26. DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors.
Shi Y; Jin J; Wang X; Ji W; Guan X
Neoplasia; 2019 Jun; 21(6):533-544. PubMed ID: 31029033
[TBL] [Abstract][Full Text] [Related]
27. TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity.
Liu Q; Chung S; Murata MM; Han B; Gao B; Zhang M; Lee TY; Chirshev E; Unternaehrer J; Tanaka H; Giuliano AE; Cui Y; Cui X
Int J Biol Sci; 2022; 18(10):4203-4218. PubMed ID: 35844787
[No Abstract] [Full Text] [Related]
28. Effective electrochemotherapy with curcumin in MDA-MB-231-human, triple negative breast cancer cells: A global proteomics study.
Mittal L; Aryal UK; Camarillo IG; Raman V; Sundararajan R
Bioelectrochemistry; 2020 Feb; 131():107350. PubMed ID: 31518962
[TBL] [Abstract][Full Text] [Related]
29. Toxoflavin analog D43 exerts antiproliferative effects on breast cancer by inducing ROS-mediated apoptosis and DNA damage.
Wu T; Liu W; Chen H; Hou L; Ren W; Zhang L; Hu J; Chen H; Chen C
Sci Rep; 2024 Feb; 14(1):4008. PubMed ID: 38369538
[TBL] [Abstract][Full Text] [Related]
30. The Effect and Mechanism of Curcumin Combined with Carboplatin Chemotherapy Promoting on Apoptosis of Lung Cancer HCC827 Cells.
Huang L; He X; Zuo X
J Immunol Res; 2022; 2022():1932692. PubMed ID: 35979255
[TBL] [Abstract][Full Text] [Related]
31. Chinese medicine formula 'Baipuhuang Keli' inhibits triple-negative breast cancer by hindering DNA damage repair via MAPK/ERK pathway.
Mi S; Liu X; Zhang L; Wang Y; Sun L; Yuan S; Cui M; Liu Y
J Ethnopharmacol; 2023 Mar; 304():116077. PubMed ID: 36572327
[TBL] [Abstract][Full Text] [Related]
32. SLFN12 Over-expression Sensitizes Triple Negative Breast Cancer Cells to Chemotherapy Drugs and Radiotherapy.
Raafat Elsayed AA; Al-Marsoummi S; Vomhof-Dekrey EE; Basson MD
Cancer Genomics Proteomics; 2022; 19(3):328-338. PubMed ID: 35430566
[TBL] [Abstract][Full Text] [Related]
33. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
[TBL] [Abstract][Full Text] [Related]
34. Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468.
Ashourpour M; Mostafavi Hosseini F; Amini M; Saeedian Moghadam E; Kazerouni F; Arman SY; Shahsavari Z
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2079-2087. PubMed ID: 34319030
[TBL] [Abstract][Full Text] [Related]
35. Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.
Yin C; Dai X; Huang X; Zhu W; Chen X; Zhou Q; Wang C; Zhao C; Zou P; Liang G; Rajamanickam V; Wang O; Zhang X; Cui R
J Cell Mol Med; 2019 Mar; 23(3):2194-2206. PubMed ID: 30609207
[TBL] [Abstract][Full Text] [Related]
36. Curcumin-induced antitumor effects on triple-negative breast cancer patient-derived xenograft tumor mice through inhibiting salt-induced kinase-3 protein.
Cheng TC; Sayseng JO; Tu SH; Juan TC; Fang CL; Liao YC; Chu CY; Chang HW; Yen Y; Chen LC; Ho YS
J Food Drug Anal; 2021 Dec; 29(4):622-637. PubMed ID: 35649138
[TBL] [Abstract][Full Text] [Related]
37. Ultra-microsecond pulsed curcumin for effective treatment of triple negative breast cancers.
Mittal L; Raman V; Camarillo IG; Sundararajan R
Biochem Biophys Res Commun; 2017 Sep; 491(4):1015-1020. PubMed ID: 28780353
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Cytotoxic Effects of the Novel Antineoplastic Agent 1,4,5-Oxathiazinane-4,4-dioxide on Triple Negative Breast Cancer Cells.
Jinih M; Wang JH; Pfirrmann RW; O'Leary DP; Corrigan MA; Redmond HP
Anticancer Res; 2021 May; 41(5):2247-2256. PubMed ID: 33952451
[TBL] [Abstract][Full Text] [Related]
39. HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.
Mehta M; Basalingappa K; Griffith JN; Andrade D; Babu A; Amreddy N; Muralidharan R; Gorospe M; Herman T; Ding WQ; Ramesh R; Munshi A
Oncotarget; 2016 Oct; 7(40):64820-64835. PubMed ID: 27588488
[TBL] [Abstract][Full Text] [Related]
40. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.
Thulasiraman P; McAndrews DJ; Mohiudddin IQ
BMC Cancer; 2014 Sep; 14():724. PubMed ID: 25260874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
